Loading
HKSEHealthcareBiotechnology
Latest quote
HK$0.42
HK$0.00 · 0.00%
China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.
Latest quote
HK$0.42
HK$0.00 · 0.00%
Regular session · HKT · Market data may be delayed.
China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.
Day range
Current HK$0.42
52-week range
Current HK$0.42
Regular session · HKT · Market data may be delayed.
China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.
Day range
Current HK$0.42
52-week range
Current HK$0.42
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 24.16M CNY | 37.96M CNY | 7.37M CNY | 207.09M CNY | 226.7M CNY |
| Cost of goods sold | 14.55M CNY | 32.7M CNY | — | 81.81M CNY | 81.24M CNY |
| Gross profit | 9.61M CNY | 5.26M CNY | 7.37M CNY | 125.29M CNY | 145.46M CNY |
| Research and development | — | — | — | 3.76M CNY | 5.96M CNY |
| Selling, general, and administrative | 21.97M CNY | 18.49M CNY | 58.76M CNY | 22.62M CNY | 230.52M CNY |
| Operating expenses | 21.97M CNY | 18.49M CNY | 63.57M CNY | 26.42M CNY | 244.01M CNY |
| Interest income | 6.82K CNY | 11K CNY | 9K CNY | 40K CNY | 239K CNY |
| Interest expense | 27.12M CNY | 31.54M CNY | 28.82M CNY | 39.37M CNY | 88.73M CNY |
| Depreciation and amortization | 48K CNY | 4.58M CNY | 5.88M CNY | 21.07M CNY | 42.25M CNY |
| Operating income | −12.36M CNY | −13.23M CNY | −56.21M CNY | −26.54M CNY | −99.43M CNY |
| Net income | −26.04M CNY | −53.36M CNY | −143.59M CNY | −66.41M CNY | −149.54M CNY |
Company facts updated Sep 6, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.035
2018 complete year+250.0% since 2016
HK$0.01
2,016
HK$0.025
2,017
HK$0.035
2,018
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jul 10, 2018 | HK$0.035Annual | Jul 11, 2018 | Aug 2, 2018 |
Dividend | Jun 8, 2017 | HK$0.025Annual | Jun 9, 2017 | Jul 3, 2017 |
Dividend | May 31, 2016 | HK$0.01Annual | Jun 1, 2016 | Jun 15, 2016 |
Ex-dividend Jul 10, 2018
HK$0.035
Annual
Record Jul 11, 2018 · Payment Aug 2, 2018
Ex-dividend Jun 8, 2017
HK$0.025
Annual
Record Jun 9, 2017 · Payment Jul 3, 2017
Ex-dividend May 31, 2016
HK$0.01
Annual
Record Jun 1, 2016 · Payment Jun 15, 2016
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
